Company
Rinn Therapeutics Limited
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Rinn Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 17/12/2024
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Epidarex Capital III UK, LP
75-100% shares, 75-100% voting · notified 2024-12-17
Group
- Rinn Therapeutics Limited
is controlled by Epidarex Capital III UK, LP
Evidence
active 75-100% shares, 75-100% voting · notified 2024-12-17 · source: Companies House PSC register - Epidarex Capital III UK, LP
is controlled by Epidarex Capital III UK GP, LP
Evidence
active right to appoint and remove person · notified 2019-04-01 · source: Companies House PSC register - Epidarex Capital III UK GP, LP
is controlled by Epidarex Capital Partners Limited
Evidence
active part right to share surplus assets 75 to 100 percent · notified 2019-03-29 · source: Companies House PSC register - Epidarex Capital Partners Limited
is controlled by Elizabeth Ann Roper
Evidence
ceased 25-50% shares, 25-50% voting · notified 2016-04-06, ceased 2019-06-17 · source: Companies House PSC register
Ultimately controlled by Elizabeth Ann Roper.
13 other companies in this group
- Epidarex Capital FP, LLP
- Epidarex Exeed Limited
- Epidarex Capital III UK GP, LP
- Adorx Therapeutics Limited
- Epidarex Capital Partners Limited
- Epidarex Capital II GP, LP
- Lunac Therapeutics Limited
- Macomics LTD
- Epidarex Capital CP, LLP
- Clyde Biosciences Limited
- EPX II CO-Invest LP
- Epidarex Capital UK GP, LLP
- Epidarex Capital III UK, LP
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Pete Finan Director · appointed 2024
- Dr Henning Klaus-Willi Christian Steinhagen Director · appointed 2024
- Dr Elizabeth Ann Roper Director · appointed 2024
First-time vs portfolio directors
First-time (1)
- Pete Finan Director · appointed 2024
Portfolio (2)
- Dr Henning Klaus-Willi Christian Steinhagen Director · appointed 2024
- Dr Elizabeth Ann Roper Director · appointed 2024
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- SC832066
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data